rs2284416

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.412-12365A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.47 in 152,084 control chromosomes in the GnomAD database, including 17,427 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 17427 hom., cov: 32)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.200

Publications

4 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.546 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.412-12365A>C intron_variant Intron 3 of 13 ENST00000609686.4 NP_000825.2 Q13224A0A8D9PHB2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.412-12365A>C intron_variant Intron 3 of 13 1 NM_000834.5 ENSP00000477455.1 Q13224
GRIN2BENST00000630791.3 linkc.412-12365A>C intron_variant Intron 4 of 14 5 ENSP00000486677.3 A0A0D9SFK0
GRIN2BENST00000714048.1 linkn.412-12365A>C intron_variant Intron 3 of 12 ENSP00000519339.1

Frequencies

GnomAD3 genomes
AF:
0.470
AC:
71354
AN:
151966
Hom.:
17400
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.389
Gnomad AMI
AF:
0.663
Gnomad AMR
AF:
0.424
Gnomad ASJ
AF:
0.522
Gnomad EAS
AF:
0.209
Gnomad SAS
AF:
0.415
Gnomad FIN
AF:
0.443
Gnomad MID
AF:
0.456
Gnomad NFE
AF:
0.551
Gnomad OTH
AF:
0.490
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.470
AC:
71438
AN:
152084
Hom.:
17427
Cov.:
32
AF XY:
0.459
AC XY:
34105
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.390
AC:
16182
AN:
41486
American (AMR)
AF:
0.425
AC:
6488
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.522
AC:
1813
AN:
3470
East Asian (EAS)
AF:
0.210
AC:
1086
AN:
5178
South Asian (SAS)
AF:
0.416
AC:
2006
AN:
4818
European-Finnish (FIN)
AF:
0.443
AC:
4680
AN:
10568
Middle Eastern (MID)
AF:
0.452
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
0.551
AC:
37420
AN:
67962
Other (OTH)
AF:
0.485
AC:
1027
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1919
3838
5758
7677
9596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.499
Hom.:
2516
Bravo
AF:
0.465
Asia WGS
AF:
0.345
AC:
1203
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.3
DANN
Benign
0.61
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2284416; hg19: chr12-13919214; API